Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of live metastases

Annals of Oncology

Volumn 9, Issue 4, 1998, Pages 397-401

  Hustinx, R ^a,b   Paulus, P ^a   Jacquet, N ^a   Jerusalem, G ^a   Bury, T ^a   Rigo, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Cancer; FDG; Liver metastasis; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 0031745316     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008290027419     Document Type: Article

References (26)

1. Jacobs J, Birnbaum B, Computed tomography imaging of focal hepatic liver lesions. Semin Roentgenol 1995; XXX (4): 308-23.
2. Adson MA, Van Heerden JA, Ason MH et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984; 119: 647-51.
3. Malt RA. Current concept: Surgery for hepatic neoplasms. N Engl J Med 1985; 313: 1591-6.
4. Sugarbaker PH, Kemeny N. Management of metastatic liver cancer. Adv Surg 1988; 22; 1-55.
5. Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990; 174: 621-6.
6. Baker ME, Pelley R. Hepatic metastases: Basic principles and implications for radiologists. Radiology 1995; 197: 329-37.
7. Warburg O. The Metabolism of Tumors. New York: Smith RR 1931; 129-69.
8. Hatanaka M. Transport of sugar in tumor cell membranes. Biochem Biophys Acta 1974; 355: 77-104.
9. Weber G. Enzymology of cancer cells. N Engl J Med 1977; 296: 541-51.
10. Rigo P, Paulus P, Kaschten BJ et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucleic Med 1996; 12: 1641-74.
11. Wahl RL. Positron emission tomography: Application in oncology. In Murray ICP, Ell PJ (eds): Nuclear Medicine, Clinical Diagnosis and Treatment. London: Churchill Livingstone 1995; 801-20.
12. Conti PS, Lilien DL, Hawley E et al. PET and 18F-FDG in oncology: A clinical update. Nucl Med Biol 1996; 23: 717-35.
13. Ferrucci J. Liver tumor imaging: Current concepts. AJR 1990; 155: 473-84.
14. de Lange EE. Cross-sectional imaging of the liver. Baillière's Clin Gastroenterol 1995; 9 (1): 97-120.
15. Kuszyk B, Bluemke D. Urban B et al. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: Sensitivity based on comparison with intraoperative and pathologic findings. AJR 1996; 166: 91-5.
16. Zeman R, Silverman P, Cooper C et al. Helical (spiral) computed tomography. Implications for imaging of the abdomen. Gastoenterol Clin North Am 1995; 24 (2): 183-99.
17. Bonaldi V, Bret P, Reinhold C et al. Helical CT of the liver: Value of an early hepatic arterial phase. Radiology 1995; 197: 357-63.
18. Van Ooijen B, Oudkerk M, Schmitz P et al. Detection of liver metastases from colorectal carcinoma: Is there a place for routine computed tomography arteriography? Surgery 1996; 119 (5): 511-6.
19. Vitola J, Delbeke D, Sandler P et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996; 171: 21-6.
20. Schiepers C, Penninckx F, De Vadder N et al. Contribution of PET in the diagnosis of recurrent coloreclal cancer: Comparison with conventional imaging. Eur J Surg One 1995; 21: 517-22.
21. Hagspiel K, Neidl K, Eichenberger A et al. Detection of liver metastases: Comparison of superparamagnetic iro oxide-enhanced and unenhanced MR imaging at 1.5T with dynamic CT. intraoperative US, and percutaneous US. Radiology 1995; 196: 471-8.
22. Zerhouni E, Rutter C, Hamilton S et al. CT and MR imaging in the staging of colorectal carcinoma: Report of the Radiology Diagnostic Oncology Group II. Radiology 1996; 200: 443-51.
23. de Lange EE, Mugler J, Gay S et al. Focal liver disease: Comparison of breath-hold T1-weighted MP-GRE MR imaging and contrast-enhanced CT. Lesion detection, localization, and characterization. Radiology 1996; 200: 465-73.
24. Seneterre E, Taourel P, Bouvier P et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785-92.
25. Vogl T, Hammerstingl R. Schwarz M et al. Superparamagnetic iron oxide-enhanced MR imaging for diffential giagnosis of focal liver lesions. Radiology 1996; 198: 881-7.
26. Rummeny E, Wernecke K, Saini S et al. Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: A receiver operating characteristic analysis. Radiology 1992; 182: 879-86.